Skip to content

Ketamine in Central Sensitization

Ketamine Use in Central Sensitization: a Study Evaluating the Use of Ketamine in Centrally Sensitized Endometriosis Patients

Status
Withdrawn
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07182032
Enrollment
0
Registered
2025-09-19
Start date
2026-02-01
Completion date
2028-06-30
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pelvic Pain, Endometriosis

Keywords

ketamine, central sensitization

Brief summary

The purpose of this research study is to see if ketamine infusion during surgery can decrease pain after surgery. Ketamine is a medication commonly used as part of anesthesia during surgery and is approved by the US FDA. Patients will be randomized to either receive standard anesthesia with OR without ketamine. The surgical procedure will be the same regardless of which group patients are randomized to. After surgery, patients will be asked to rate their pain in the post-operative observation unit and at their two-week post-operative visit. No additional visits are required for participation in this study. The investigators estimate the surveys will take approximately 10 minutes to complete.

Interventions

DRUGketamine

Participants will receive general anesthesia with protocoled ketamine infusion

Sponsors

University Hospitals Cleveland Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

* age range 18-89 * ASA classification I-III * outpatient elective laparoscopy for endometriosis

Exclusion criteria

* known allergy or contraindication to ketamine * History of substance use disorder, including alcohol or marijuana use, both current and remote * History of severe psychiatric illness, including schizoaffective disorder, bipolar disorder, psychosis, or decompensated psychiatric condition , excluding anxiety and depression * Current Intraoperative complications

Design outcomes

Primary

MeasureTime frameDescription
change in pain as measured by visual analog scaleapproximately post-operative day 0 and 14A Visual Analog Scale (VAS) is a tool for patients to rate their pain on a 100mm line, where "no pain" is at one end and "worst pain imaginable" is at the other.

Secondary

MeasureTime frameDescription
Intraoperative opioid consumption as measured by anesthesia chartingIntraoperatively up to 8 hoursReported in morphine equivalents
change in postoperative pain scores measured by numerical rating scaleapproximately postoperative day 0 and 14NRS is a simple and widely used pain assessment tool that asks patients to rate their pain intensity on a scale from 0 (no pain) to 10 (severe pain).
incidence of postoperative nausea/vomiting as measured by patient reportpostoperative day 0
change in total analgesic consumption post-surgery as measured by chart review and patient reportapproximately postoperative day 0, 1 and 14measured in morphine milliequivalents
incidence of postoperative delirium as measured by chart reviewpostoperative day 0
change in central sensitization as measured by central sensitization inventory (CSI) scoreapproximately postoperative day 0 and 14The CSI consists of 25 questions, each rated on a 0-4 scale (0 = never, 4 = always). The total score ranges from 0 to 100. Higher scores indicate a greater degree of central sensitization.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORAdi Cosic, DO

University Hospitals

PRINCIPAL_INVESTIGATORMorgan Cheeks, MD

University Hosptials

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 12, 2026